Global Point of Care (POC) Molecular Diagnostics Market Overview:
Global Point of Care (POC) Molecular Diagnostics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Point of Care (POC) Molecular Diagnostics Market Report 2026 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Point of Care (POC) Molecular Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Point of Care (POC) Molecular Diagnostics Market:
The Point of Care (POC) Molecular Diagnostics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Point of Care (POC) Molecular Diagnostics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Point of Care (POC) Molecular Diagnostics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Point of Care (POC) Molecular Diagnostics market has been segmented into:
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based
By Application, Point of Care (POC) Molecular Diagnostics market has been segmented into:
Infectious Diseases
Oncology
Hematology
Other Applications
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Point of Care (POC) Molecular Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Point of Care (POC) Molecular Diagnostics market.
Top Key Players Covered in Point of Care (POC) Molecular Diagnostics market are:
Bayer AG
Danaher Corporation
DiaSorin SpA
Biocartis NV
Maxim Biomedical Inc.
AccuBioTech Co. Ltd.
Abacus Diagnostica Oy
genedrive plc
Molbio Diagnostics Pvt. Ltd.
Mesa Biotech Inc.
Binx Health
Credo Diagnostics Biomedical Pte. Ltd
Genestat Molecular Diagnostics
LLC
Alveo Technologies
ADOR Diagnostics
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Point of Care (POC) Molecular Diagnostics Market Type
4.1 Point of Care (POC) Molecular Diagnostics Market Snapshot and Growth Engine
4.2 Point of Care (POC) Molecular Diagnostics Market Overview
4.3 PCR-based
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 PCR-based: Geographic Segmentation Analysis
4.4 Genetic Sequencing-based
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Genetic Sequencing-based: Geographic Segmentation Analysis
4.5 Hybridization-based
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Hybridization-based: Geographic Segmentation Analysis
4.6 Microarray-based
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Microarray-based: Geographic Segmentation Analysis
Chapter 5: Point of Care (POC) Molecular Diagnostics Market Application
5.1 Point of Care (POC) Molecular Diagnostics Market Snapshot and Growth Engine
5.2 Point of Care (POC) Molecular Diagnostics Market Overview
5.3 Infectious Diseases
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Infectious Diseases: Geographic Segmentation Analysis
5.4 Oncology
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Oncology: Geographic Segmentation Analysis
5.5 Hematology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Hematology: Geographic Segmentation Analysis
5.6 Other Applications
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Other Applications: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Point of Care (POC) Molecular Diagnostics Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BAYER AG; DANAHER CORPORATION; DIASORIN SPA; BIOCARTIS NV; MAXIM BIOMEDICAL
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; ACCUBIOTECH CO.
6.4 LTD.; ABACUS DIAGNOSTICA OY; GENEDRIVE PLC; MOLBIO DIAGNOSTICS PVT. LTD.; MESA BIOTECH
6.5 INC.; BINX HEALTH; CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD; GENESTAT MOLECULAR DIAGNOSTICS
6.6 LLC; ALVEO TECHNOLOGIES; ADOR DIAGNOSTICS
Chapter 7: Global Point of Care (POC) Molecular Diagnostics Market By Region
7.1 Overview
7.2. North America Point of Care (POC) Molecular Diagnostics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 PCR-based
7.2.2.2 Genetic Sequencing-based
7.2.2.3 Hybridization-based
7.2.2.4 Microarray-based
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Infectious Diseases
7.2.3.2 Oncology
7.2.3.3 Hematology
7.2.3.4 Other Applications
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Point of Care (POC) Molecular Diagnostics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 PCR-based
7.3.2.2 Genetic Sequencing-based
7.3.2.3 Hybridization-based
7.3.2.4 Microarray-based
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Infectious Diseases
7.3.3.2 Oncology
7.3.3.3 Hematology
7.3.3.4 Other Applications
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Point of Care (POC) Molecular Diagnostics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 PCR-based
7.4.2.2 Genetic Sequencing-based
7.4.2.3 Hybridization-based
7.4.2.4 Microarray-based
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Infectious Diseases
7.4.3.2 Oncology
7.4.3.3 Hematology
7.4.3.4 Other Applications
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Point of Care (POC) Molecular Diagnostics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 PCR-based
7.5.2.2 Genetic Sequencing-based
7.5.2.3 Hybridization-based
7.5.2.4 Microarray-based
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Infectious Diseases
7.5.3.2 Oncology
7.5.3.3 Hematology
7.5.3.4 Other Applications
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Point of Care (POC) Molecular Diagnostics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 PCR-based
7.6.2.2 Genetic Sequencing-based
7.6.2.3 Hybridization-based
7.6.2.4 Microarray-based
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Infectious Diseases
7.6.3.2 Oncology
7.6.3.3 Hematology
7.6.3.4 Other Applications
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Point of Care (POC) Molecular Diagnostics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 PCR-based
7.7.2.2 Genetic Sequencing-based
7.7.2.3 Hybridization-based
7.7.2.4 Microarray-based
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Infectious Diseases
7.7.3.2 Oncology
7.7.3.3 Hematology
7.7.3.4 Other Applications
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Point of Care (POC) Molecular Diagnostics Scope:
|
Report Data
|
Point of Care (POC) Molecular Diagnostics Market
|
|
Point of Care (POC) Molecular Diagnostics Market Size in 2025
|
USD XX million
|
|
Point of Care (POC) Molecular Diagnostics CAGR 2025 - 2032
|
XX%
|
|
Point of Care (POC) Molecular Diagnostics Base Year
|
2024
|
|
Point of Care (POC) Molecular Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Bayer AG, Danaher Corporation, DiaSorin SpA, Biocartis NV, Maxim Biomedical Inc., AccuBioTech Co. Ltd., Abacus Diagnostica Oy, genedrive plc, Molbio Diagnostics Pvt. Ltd., Mesa Biotech Inc., Binx Health, Credo Diagnostics Biomedical Pte. Ltd, Genestat Molecular Diagnostics, LLC, Alveo Technologies, ADOR Diagnostics.
|
|
Key Segments
|
By Type
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based
By Applications
Infectious Diseases
Oncology
Hematology
Other Applications
|
